Log In
Print
BCIQ
Print
Print this Print this
 

Debio 0719

  Manage Alerts
Collapse Summary General Information
Company Kyowa Hakko Kirin Co. Ltd.
DescriptionSelective inhibitor of lysophosphatidic acid receptor 1 (LPAR1) and type 3 (LPA3)
Molecular Target Lysophosphatidic acid receptor 1 (LPAR1) (EDG2) (LPA1) ; Lysophosphatidic acid receptor 3 (LPAR3) (EDG7) (LPA3)
Mechanism of ActionUndisclosed
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat metastatic cancer
Regulatory Designation

Partner

Debiopharm Group


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today